Acquisition StrategyTELUS has upped its bid to complete the acquisition of full ownership in TIXT to US$4.50/sh from US$3.40/sh, which is supported by Baring, a major shareholder, indicating a high probability of deal closure.
Cash FlowAdjusted free cash flow came in at $535 million, well ahead of expectations.
Financial PerformanceTELUS Health showed strong performance with adjusted EBITDA at $91 million, a 30% increase, due to strong synergies from LifeWorks.